CTOs on the Move


 
HOB is a Hawthorne, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.hobsoft.com
  • 245 Saw Mill River Rd
    Hawthorne, NY USA 10532
  • Phone: 914.239.5261

Executives

Name Title Contact Details

Similar Companies

Dentek Inc

Dentek Inc is a Overland Park, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Implant Sciences

Implant Sciences is the leader in next generation Explosives Trace Detection (ETD) technology. In January 2013, the Company became only the third ETD manufacturer, and the sole American-owned company, to have product approval from the US Transportation Security Administration.   Implant Sciences has developed proprietary technologies used in its commercial explosives and drugs trace detection systems, which ship to a growing number of locations domestically and internationally.   Implant Sciences' QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation and, in addition to receiving TSA qualification for air cargo screening, the Company's QS-B220 has also received STAC certification, a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act), and  the GSN 2013 Homeland Security Award for "Best Explosives Detection Solution".

Miltex

For more than 50 years, Miltex, Inc. has established itself as the largest and most respected supplier of hand-held surgical instruments in the alternate site market. Unique among its competitors, Miltex, Inc., through Miltex GmbH in Rietheim-Weiltheim,

MCD

MCD is a Augusta, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vermillion

Vermillion`s vision is to become a recognized leader in the advancement of women`s health by providing innovative methods to detect, monitor and manage the treatment of gynecologic cancers and other related diseases. We will develop and commercialize high-value, multi-marker, diagnostic tests which address unmet needs in gynecologic oncology and women’s health. We will accomplish our mission through internal development, targeted acquisitions, and collaborations with leading scientific and clinical institutions. Our global commercial efforts will include direct marketing and sales activities as well as partnerships with leading companies in women’s health.